Leidos Holdings Inc (LDOS) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock is currently under pressure due to significant downgrades from analysts, concerns over its healthcare business, and bearish technical indicators. While hedge funds are buying, the lack of positive trading signals and the absence of strong catalysts suggest holding off on investment for now.
The technical indicators for LDOS are bearish. The MACD is negatively expanding (-1.041), RSI is at 6.713 indicating oversold conditions, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with S1 at 109.047 and S2 at 104.063.

Hedge funds are increasing their positions, with buying activity up 348.79% over the last quarter.
Significant analyst downgrades from BofA and Jefferies, citing pressures in the healthcare business and limited EPS growth potential. The stock recently dropped 11% following these downgrades. Additionally, technical indicators are bearish, and there is no recent congress trading data or strong trading signals.
No financial performance data available for the latest quarter.
Analysts have downgraded the stock significantly. BofA downgraded LDOS to Neutral from Buy, reducing the price target to $125 from $200. Jefferies also downgraded the stock to Hold from Buy, with a price target of $140, down from $185. Other firms have also lowered price targets, citing pressures in the healthcare and defense portfolios.